Point72 Hong Kong’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-13,966
Closed -$2.31M 2623
2021
Q2
$2.31M Buy
13,966
+1,094
+8% +$183K 0.07% 373
2021
Q1
$1.97M Buy
+12,872
New +$1.75M 0.07% 401
2020
Q3
Sell
-5,497
Closed -$535K 1668
2020
Q2
$535K Buy
+5,497
New +$512K 0.06% 323
2019
Q2
Sell
-1,621
Closed -$179K 1520
2019
Q1
$179K Buy
+1,621
New +$169K 0.07% 205
2018
Q4
Sell
-23
Closed -$3K 1316
2018
Q3
$3K Buy
+23
New +$2.4K ﹤0.01% 757
2017
Q3
Sell
-248
Closed -$19K 1147
2017
Q2
$19K Buy
248
+234
+1,671% +$16.2K 0.02% 386
2017
Q1
$1K Sell
14
-79
-85% -$4.65K ﹤0.01% 695
2016
Q4
$5K Sell
93
-407
-81% -$22.3K 0.01% 728
2016
Q3
$28K Buy
+500
New +$24.5K 0.02% 545

Other funds holding PRAH

Point72 Hong Kong's PRAH Position: Q3 2021 in Review

Point72 Hong Kong sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 13,966 shares — an estimated $2.31M sold.

Point72 Hong Kong first reported a position in PRAH in Q3 2016 and held it in 9 quarters. The position peaked at $2.31M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Point72 Hong Kong reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 13,966 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $2.31M.
  • Point72 Hong Kong first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 9 quarters.
  • Point72 Hong Kong's PRA Health Sciences, Inc. position peaked at $2.31M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Point72 Hong Kong's 13F filing for Q3 2021, filed 15 Nov 2021.